Annual CFO
-$97.05 M
-$26.28 M-37.13%
31 December 2023
Summary:
RAPT Therapeutics annual cash flow from operations is currently -$97.05 million, with the most recent change of -$26.28 million (-37.13%) on 31 December 2023. During the last 3 years, it has fallen by -$56.56 million (-139.68%). RAPT annual CFO is now -257.81% below its all-time high of -$27.12 million, reached on 31 December 2017.RAPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$17.62 M
+$10.53 M+37.41%
30 September 2024
Summary:
RAPT Therapeutics quarterly cash flow from operations is currently -$17.62 million, with the most recent change of +$10.53 million (+37.41%) on 30 September 2024. Over the past year, it has increased by +$4.26 million (+19.48%). RAPT quarterly CFO is now -209.81% below its all-time high of -$5.69 million, reached on 31 December 2019.RAPT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$100.61 M
+$4.26 M+4.06%
30 September 2024
Summary:
RAPT Therapeutics TTM cash flow from operations is currently -$100.61 million, with the most recent change of +$4.26 million (+4.06%) on 30 September 2024. Over the past year, it has dropped by -$8.47 million (-9.19%). RAPT TTM CFO is now -1220.91% below its all-time high of -$7.62 million, reached on 31 March 2018.RAPT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.1% | +19.5% | -9.2% |
| 3 y3 years | -139.7% | -40.8% | -80.6% |
| 5 y5 years | -194.5% | -45.2% | -158.0% |
RAPT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -139.7% | at low | -40.8% | +38.8% | -80.6% | +4.7% |
| 5 y | 5 years | -194.5% | at low | -209.8% | +38.8% | -226.5% | +4.7% |
| alltime | all time | -257.8% | at low | -209.8% | +38.8% | -1220.9% | +4.7% |
RAPT Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.62 M(-37.4%) | -$100.61 M(-4.1%) |
| June 2024 | - | -$28.15 M(+4.0%) | -$104.88 M(-0.6%) |
| Mar 2024 | - | -$27.08 M(-2.4%) | -$105.53 M(+8.7%) |
| Dec 2023 | -$97.05 M(+37.1%) | -$27.75 M(+26.8%) | -$97.05 M(+5.3%) |
| Sept 2023 | - | -$21.88 M(-24.0%) | -$92.14 M(+5.4%) |
| June 2023 | - | -$28.81 M(+54.9%) | -$87.41 M(+18.4%) |
| Mar 2023 | - | -$18.60 M(-18.6%) | -$73.80 M(+4.3%) |
| Dec 2022 | -$70.77 M(+16.0%) | -$22.85 M(+33.2%) | -$70.77 M(+3.2%) |
| Sept 2022 | - | -$17.15 M(+12.9%) | -$68.60 M(+7.2%) |
| June 2022 | - | -$15.20 M(-2.5%) | -$63.97 M(+2.0%) |
| Mar 2022 | - | -$15.58 M(-24.7%) | -$62.69 M(+2.7%) |
| Dec 2021 | -$61.03 M | -$20.68 M(+65.2%) | -$61.03 M(+9.5%) |
| Sept 2021 | - | -$12.52 M(-10.0%) | -$55.71 M(+4.8%) |
| June 2021 | - | -$13.92 M(+0.0%) | -$53.15 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$13.91 M(-9.5%) | -$45.66 M(+12.8%) |
| Dec 2020 | -$40.49 M(+14.1%) | -$15.37 M(+54.4%) | -$40.49 M(+31.4%) |
| Sept 2020 | - | -$9.95 M(+54.9%) | -$30.81 M(-6.6%) |
| June 2020 | - | -$6.43 M(-26.5%) | -$33.00 M(-7.3%) |
| Mar 2020 | - | -$8.74 M(+53.7%) | -$35.59 M(+0.3%) |
| Dec 2019 | -$35.47 M(+7.7%) | -$5.69 M(-53.1%) | -$35.47 M(-9.0%) |
| Sept 2019 | - | -$12.14 M(+34.7%) | -$39.00 M(+9.2%) |
| June 2019 | - | -$9.01 M(+4.4%) | -$35.72 M(+5.2%) |
| Mar 2019 | - | -$8.63 M(-6.3%) | -$33.97 M(+3.1%) |
| Dec 2018 | -$32.95 M(+21.5%) | -$9.21 M(+3.9%) | -$32.95 M(+38.8%) |
| Sept 2018 | - | -$8.86 M(+22.0%) | -$23.74 M(+59.6%) |
| June 2018 | - | -$7.26 M(-4.7%) | -$14.88 M(+95.3%) |
| Mar 2018 | - | -$7.62 M | -$7.62 M |
| Dec 2017 | -$27.12 M | - | - |
FAQ
- What is RAPT Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for RAPT Therapeutics?
- What is RAPT Therapeutics annual CFO year-on-year change?
- What is RAPT Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly CFO year-on-year change?
- What is RAPT Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for RAPT Therapeutics?
- What is RAPT Therapeutics TTM CFO year-on-year change?
What is RAPT Therapeutics annual cash flow from operations?
The current annual CFO of RAPT is -$97.05 M
What is the all time high annual CFO for RAPT Therapeutics?
RAPT Therapeutics all-time high annual cash flow from operations is -$27.12 M
What is RAPT Therapeutics annual CFO year-on-year change?
Over the past year, RAPT annual cash flow from operations has changed by -$26.28 M (-37.13%)
What is RAPT Therapeutics quarterly cash flow from operations?
The current quarterly CFO of RAPT is -$17.62 M
What is the all time high quarterly CFO for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly cash flow from operations is -$5.69 M
What is RAPT Therapeutics quarterly CFO year-on-year change?
Over the past year, RAPT quarterly cash flow from operations has changed by +$4.26 M (+19.48%)
What is RAPT Therapeutics TTM cash flow from operations?
The current TTM CFO of RAPT is -$100.61 M
What is the all time high TTM CFO for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM cash flow from operations is -$7.62 M
What is RAPT Therapeutics TTM CFO year-on-year change?
Over the past year, RAPT TTM cash flow from operations has changed by -$8.47 M (-9.19%)